David Kirn, MD
Jennerex Biotherapeutics (Jennerex, Inc.) · Jennerex Inc. · Jennerex Biotherapeutics
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Kirn, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:40 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT00629759 · A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic CarcinomaJennerex Biotherapeutics · completed · Neoplasms, Liver · study director
- Ph1NCT00625456 · Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid TumorsJennerex Biotherapeutics · completed · Melanoma, Lung Cancer, Renal Cell Carcinoma · study director
- Ph2NCT00554372 · A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular CarcinomaJennerex Biotherapeutics · completed · Carcinoma, Hepatocellular · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.